Angela Haupt13:19, May 09 2021
Sleep deprivation has been linked to hypertension, obesity and diabetes and has long been suspected of having a connection to dementia. Now, a large new study has more clearly established that association by concluding that people who sleep less than six hours a night in midlife have a greater risk of developing late-onset dementia. That doesn t mean middle-aged short sleepers should panic, according to experts. Although the study is an important step forward, much about the connection between sleep and dementia remains unknown, they said. Still, it can t hurt to work on your sleep habits while research continues, and you ll find some strategies listed below.
Dementia and sleep deprivation linked in recent study washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
A team of researchers including Worcester Polytechnic Institute Biology Professor Pamela Weathers has found that extracts from a medicinal herb known as sweet wormwood can inhibit the COVID-19 virus and two of its recent variants.
Laboratory Findings Suggest Artemisia Annua May Point to Treatment for SARS-CoV-2
May 4, 2021
A team of researchers that includes Worcester Polytechnic Institute Biology Professor Pamela Weathers has found that extracts from the leaves of the
Artemisia annua plant, a medicinal herb also known as sweet wormwood, inhibit the replication of the SARS-CoV-2 virus and two of its recent variants.
The team, which included researchers from Columbia University in New York and the University of Washington at Seattle, also found that extracts of the plant were more effective against the virus when levels of a key therapeutic compound in the plant, artemisinin, were low. The
https://www.afinalwarning.com/511963.html (Natural News) On Wednesday, April 14, the
Centers for Disease Control and Prevention (CDC) announced that it had learned of a seventh woman who developed a severe blood clot after being inoculated with the vaccine developed by Johnson & Johnson.
The revelation of the seventh blood clotting case comes as the CDC’s Advisory Committee on Immunization Practices (ACIP) debates whether or not the Johnson & Johnson vaccine should be used by the public or discontinued. The ACIP also met to discuss whether it could make an interim age or risk-factor based recommendation regarding the shot.
In the end, the committee came to the conclusion that it needed more information, and it felt it was inappropriate to release a definitive statement regarding the Johnson & Johnson vaccine.